Search
for
Sort by
Research 61–90 of 1000+
- Therapeutic Potential of Chitosan-Based and Related Nanocomposite Systems in Wound Management: A Review
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- The Potential Reversible Transition between Stem Cells and Transient-Amplifying Cells: The Limbal Epithelial Stem Cell Perspective
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Assessing the relationship between dietary factors and hair health: A systematic review
- Bazi Bushen capsule alleviates skin photoaging by targeting the KEAP1–NRF2 pathway
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- Silk fibroin hydrogel with recombinant silk fibroin/NT3 protein enhances wound healing by promoting Type III collagen synthesis and hair follicle regeneration in skin injury
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- MK-386, an Inhibitor of 5α-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in Semen<sup>1</sup>
- Efficacy of <i>Cistanche Tubulosa</i> and <i>Laminaria Japonica</i> Extracts (MK-R7) Supplement in Preventing Patterned Hair Loss and Promoting Scalp Health
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- Topical MK-386 (M), an inhibitor of 5α-reductase (5αr) type I, suppresses sebum dht.
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Effects of Finasteride (MK-906), a 5<i>α</i>-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men
- Biotransformation of Finasteride (MK-0906) by Selenastrum capricornutum (Green Algae)
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- The effects of acute finasteride treatment in dopamine transporter knockout mice and MK-801-treated mice
- Sex Differences in Reaction to Chronic Unpredictable Stress in the House Mouse (<em>Mus m. musculus</em>) of Wild Origin
- Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagogue
- The 5α-Recluctase System and Its Inhibitors
- Anabolic effects of testosterone are preserved during inhibition of 5α-reductase
- Classification scale for male and female androgenetic alopecia.
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
- Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype